Effects of Dynamic Flex Cast With Neurodevelopmental Treatment on Gross Motor Functions in Cerebral Palsy
NCT ID: NCT05751122
Last Updated: 2023-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2023-02-25
2023-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Focal Muscle Vibration on Bio-psychosocial Outcomes in Cerebral Palsy
NCT05751135
Vestibular and Motor Functions in Children With Hemiplegic Cerebral Palsy
NCT04894812
Reverse Walking With And Without Whole Body Vibration in Children With Cerebral Palsy
NCT05763212
Comparison of Task-oriented Activity Based Neurodevelopmental Principles and Gross Motor Task Training.
NCT05981287
Lower Extremity Functional Training (LIFT) on Gross Motor Function and Gait in Children With Spastic CP
NCT05460936
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dynamic flex cast with neurodevelopmental Group
Dynamic flex cast with neurodevelopmental treatment
Dynamic flex cast with neurodevelopmental treatment
Neurodevelopmental therapy in combination with dynamic flex cast to treat experimental group.
Three times a week, 1 hour session per day.
Dynamic flex casting is casting which manipulate bone alignment and maintains range of motion or sustained stretch. Casting will be changed weekly for 3 months.
Neuro developmental approach is individualized treatment which is attuned to each child's specific problems, aims and goals.
Key elements in NDT are: facilitation (using sensory inputs to improve motor performance), management of compensatory motor behavior, and an overall management strategy (a 24-hour interdisciplinary management approach) NDT involves task specific postures and movements.
Rigid Ankle foot Orthosis with neurodevelopmental Group
Rigid Ankle foot Orthosis with neurodevelopmental treatment
Rigid Ankle foot Orthosis with neurodevelopmental treatment
Rigid ankle foot orthosis will be applied to ankle joint at the start of intervention.
Neurodevelopmental treatment will be applied to both groups with protocol; Three times a week, 1 hour session per day.
Assessment on 1st day,6th week and 12th week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dynamic flex cast with neurodevelopmental treatment
Neurodevelopmental therapy in combination with dynamic flex cast to treat experimental group.
Three times a week, 1 hour session per day.
Dynamic flex casting is casting which manipulate bone alignment and maintains range of motion or sustained stretch. Casting will be changed weekly for 3 months.
Neuro developmental approach is individualized treatment which is attuned to each child's specific problems, aims and goals.
Key elements in NDT are: facilitation (using sensory inputs to improve motor performance), management of compensatory motor behavior, and an overall management strategy (a 24-hour interdisciplinary management approach) NDT involves task specific postures and movements.
Rigid Ankle foot Orthosis with neurodevelopmental treatment
Rigid ankle foot orthosis will be applied to ankle joint at the start of intervention.
Neurodevelopmental treatment will be applied to both groups with protocol; Three times a week, 1 hour session per day.
Assessment on 1st day,6th week and 12th week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 3-8 years
* Spastic diplegic/ hemiplegic CP
* Ankle dorsiflexion 5-10 degrees
* GMFCS level 1-3
* Modified Ashworth's scale level 1+ - 3
Exclusion Criteria
* Cognitive impairments
* Secondary orthopedic, auditory and severe visual impairments
* Unwilling patients or parents
* Recent surgical interventions
3 Years
8 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Riphah International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abrish Abbasi, MS-NMPT
Role: PRINCIPAL_INVESTIGATOR
Riphah International University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chal foundation, Bacha Khan Medical Complex
Swābi, KPK, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Nafisa Gul
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.